NCT03848442

Brief Summary

The aim of the study is to evaluate the feasibility and health-related effects of an individualized 12wk 'uptime' participation intervention in girls and women with Rett syndrome. Girls and women above 5 years of age with Rett syndrome and a confirmed MECP2 mutation will be included. Each individual program focuses on participation in enjoyable activities to promote 'uptime' in home, school/day center and community settings. Primary outcomes are sedentary time and daily steps. Secondary outcomes are gross motor skills, walking capacity, quality of life and participation-level goals. Outcomes are evaluated on four occasions: at baseline and after a 6-week interval, immediately following the 12-week intervention program and 12 weeks after the intervention program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2017

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 8, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 20, 2019

Completed
Last Updated

February 21, 2019

Status Verified

February 1, 2019

Enrollment Period

10 months

First QC Date

February 8, 2019

Last Update Submit

February 20, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • ActivPAL

    Change in sedentary time

    Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up

  • Stepwatch Activity Monitor

    Change in daily step count

    Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up

Secondary Outcomes (4)

  • Rett Syndrome Gross Motor Scale

    Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up

  • 2 minute walk test

    Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up

  • Quality of Life Inventory - Disability, questionnaire

    Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up

  • Goal attainment scaling

    Assessed twice; at baseline and after the 12 week intervention

Study Arms (1)

UPART intervention group

EXPERIMENTAL

A 1-group pretest-posttest design was conducted. Outcomes were evaluated on four occasions; twice during baseline separated by six weeks and immediately following a 12-week 'uptime' participation intervention and after a further 12 weeks (follow-up).

Other: 'Uptime' participation

Interventions

The intervention are designed for each individual and are consistent with the model for participation-based interventions. The interventions are goal-oriented (meaningful and family/client-selected goals), family/client-centered (promoted self-determination and decision making), collaborative (partnership between caregivers), strength-based (built on participant and caregiver strengths) and ecological (natural environment and real-life experiences). Design of the intervention comprised three steps: 1) Preparation period (6 weeks); 2) Intervention period (12 weeks); 3) Follow-up period (12 weeks)

UPART intervention group

Eligibility Criteria

Age5 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Girls and women above 5 years of age with Rett syndrome and a confirmed MECP2 mutation
  • Hoffer ambulation scale levels I-IV

You may not qualify if:

  • Girls and women who have undergone orthopedic surgery in the lower extremities within the last 6 months
  • Girls and women who have undergone spinal fusion within the last 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Rett syndrome, Department of Paediatrics and Adolescents Medicine

Copenhagen, København Ø, 2100, Denmark

Location

MeSH Terms

Conditions

Rett Syndrome

Condition Hierarchy (Ancestors)

X-Linked Intellectual DisabilityIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeredodegenerative Disorders, Nervous System

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research physiotherapist

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 20, 2019

Study Start

February 7, 2017

Primary Completion

December 15, 2017

Study Completion

December 15, 2017

Last Updated

February 21, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations